Clinical Trial Update: Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating SX-682 alone and in combination with decitabine in patients with myelodysplastic syndromes. The study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine)
• SX-682

Snippet

Sponsor: Syntrix Biosystems, Inc. | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: RECRUITING